Evidence map›Paper›PMID 40076432›Full record

ArticleInternational journal of molecular sciences2025

Matthew E Siviski, Rachel Bercovitch, Kathleen Pyburn, Christian Potts, Shivangi R Pande, Carlos A Gartner, William Halteman, Doreen Kacer, Barbara Toomey, Calvin Vary and 5 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Matthew E SiviskiCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Rachel BercovitchCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.ORCID 0009-0003-4446-8422
Kathleen PyburnCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Christian PottsCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.ORCID 0009-0007-7794-7840
Shivangi R PandeCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Carlos A GartnerCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
William HaltemanTechnical and Administrative Services, University of Maine, Orono, ME 04469, USA.
Doreen KacerCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Barbara ToomeyCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.ORCID 0009-0006-9425-8548
Calvin VaryCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Robert KozaCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Lucy LiawCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Sergey RyzhovCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Volkhard LindnerCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.
Igor PrudovskyCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, ME 04074, USA.ORCID 0000-0002-8916-1331

Funding

The role of night shift work in metabolic disorders during and after pregnancyP20GM121301 · NIGMS · MAINEHEALTH · PI Lucy Liaw · 2017 to 2026
$25.1M
Progenitor Cell Analysis CoreP30GM106391 · NIGMS · MAINEHEALTH · PI WOJCHOWSKI, DON MICHAEL · 2013 to 2017
$5.7M
Regulation of arterial phenotype by perivascular adipose tissue in cardiometabolic diseaseR01HL141149 · NHLBI · MAINEHEALTH · PI LIAW, LUCY · 2018 to 2025
$4.3M
Effect of CTHRC1 on endothelial cell survival after acute ischemiaR01HL146504 · NHLBI · MAINEHEALTH · PI LINDNER, VOLKHARD, RYZHOV, SERGEY · 2020 to 2023
$2.1M
NHLBI NIH HHS HL146504NHLBI NIH HHS R01 HL141149NHLBI NIH HHS R01 HL146504NIGMS NIH HHS P20 GM121301NIGMS NIH HHS P30 GM106391NIH HHS 5R01HL141149NIH/NIGMS P20GM106391
6 · The paper itself

Abstract

Adipogenesis is regulated by the coordinated activity of adipogenic transcription factors including PPAR-gamma and C/EBP alpha, while dysregulated adipogenesis can predispose adipose tissues to adipocyte hypertrophy and hyperplasia. We have previously reported that

Indexed as

AdipogenesisAdipose TissueReceptor, Platelet-Derived Growth Factor alphaSOX9 Transcription FactorStromal CellsTranscription Factors3T3-L1 CellsAdipocytesAnimalsCell DifferentiationCulture Media, ConditionedHumansMicePPAR gammaSignal TransductionCulture Media, ConditionedPPAR gammaReceptor, Platelet-Derived Growth Factor alphaSOX9 protein, humanSOX9 Transcription FactorTranscription Factorsadipogenesisadipogenic gene expressioncollagen triple helix repeat-containing 1 (CTHRC1)PDGFR-alphaSRY-box transcription factor 9 (SOX9)stromal vascular cellswhite adipose tissue

Identifiers

PMID40076432
PMCPMC11898434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.